Within four weeks of treatment with bone marrow mesenchymal stem cell-derived exosomes (BMMSC-Exos), T1DM rats showed a significant reduction in blood glucose levels and increased plasma insulin levels. The gene discussed is INS; the disease is type 1 diabetes mellitus.